Are there racial and ethnic disparities in the use of novel hormonal therapy agents in men with advanced prostate cancer?

Researchers assessed ethnic and racial differences in novel hormonal therapy (NHT) use among advanced prostate cancer (PCa) patients.

Edwards receives FDA approval for first transcatheter tricuspid valve replacement treatment

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Edwards Lifesciences received approval from

February 2, 2024

Medacta Group SA revenues up +19.5% at constant currency1 exceeding the milestone of 500Mln € in FY 2023 – Biotech Investments

Medacta Group SA / Key word(s): Sales Result 02-Feb-2024 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer

February 3, 2024

Whether Once a Day or Once a Week, Any Exercise Still Counts Against CVD

As long as people got their weekly recommended moderate to vigorous physical activity (MVPA), it didn’t matter if they did it on a “weekend warrior”

July 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.